Savara Pharmaceuticals
SVRA
#6890
Rank
S$0.63 B
Marketcap
$3.69
Share price
6.15%
Change (1 day)
-43.38%
Change (1 year)

EPS for Savara Pharmaceuticals (SVRA)

EPS in 2023 (TTM): -$0.38

According to Savara Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.37. In 2022 the company made an earnings per share (EPS) of -$0.33 an increase over its 2021 EPS that were of -$0.45.

EPS history for Savara Pharmaceuticals from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.3814.33%
2022-$0.33-26.47%
2021-$0.45-59.52%
2020-$1.12-56.48%
2019-$2.582.66%
2018-$2.51-38.56%
2017-$4.09-71.06%
2016-$14.13-37.06%
2015-$22.454.35%
2014-$21.51-25.81%
2013-$28.99-8.82%
2012-$31.80-27.66%
2011-$43.96-58.41%
2010-$105.69-86%
2009-$754.784.13%
2008-$724.8524%
2007-$584.56-35.9%
2006-$911.9195%
2005-$467.6553.85%
2004-$303.9744.44%
2003-$210.44-40%
2002-$350.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.34 257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.36-3.57%๐Ÿ‡บ๐Ÿ‡ธ USA